World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01087164
Date of registration: 02/02/2009
Prospective Registration: Yes
Primary sponsor: Indiana University
Public title: Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers
Scientific title: Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers in Adolescents
Date of first enrolment: September 2010
Target sample size: 600
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT01087164
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
United States
Contacts
Name:     Vaughn I Rickert, PsyD
Address: 
Telephone:
Email:
Affiliation:  Indiana University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- The parents of adolescent males and females (aged 11-14 years) who have provided
written consent for their adolescent to receive health care services through the Teen
Health Center, Inc, a nonprofit organization that works in collaboration with the
Department of Pediatrics at the University of Texas Medical Branch, Galveston, Texas
and whose adolescents have not received their first dose of HPV vaccine, will be
eligible to participate.

Exclusion Criteria:

- Having received one or more doses of the HPV vaccine Gardasil



Age minimum: 11 Years
Age maximum: 15 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Human Papillomavirus Infection
Intervention(s)
Behavioral: Message sidedness
Behavioral: Compliance
Primary Outcome(s)
Gardasil immunization [Time Frame: One year]
Secondary Outcome(s)
Message type [Time Frame: Two years]
Gender [Time Frame: One year]
Completion of three dose series of Gardasil [Time Frame: Three years]
Secondary ID(s)
0911-50
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Merck Sharp & Dohme Corp.
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history